XCELERON

Chemical services, namely, conducting chemical research and chemical analyses, chemical laboratories; pharmacological services, namely, pharmaceutical and biotechnology drug development services; biological services, namely, drug metabolism studies, conducting pharmacokinetics studies, conducting analyses of biomarkers altered as a result of drug treatment; [ pathological services, namely, clinical pathology testing; ] drug and metabolite analysis, measurement of intermediary metabolites, including but not limited to Krebs cycle intermediates and intermediates in the prostaglandin pathway

[ Medical testing and analysis services, namely, medical testing services and clinical diagnosis services; medical diagnostic services to detect intermediary metabolism deficiencies, hormone deficiencies and metabolic dysfunction, including liver or kidney failure. ]